: MeSH: Virosomes

Therapeutics > Drug Therapy > Drug Delivery Systems > Drug Carriers > Virosomes

Pharmaceutical Preparations > Dosage Forms > Drug Carriers > Virosomes

Investigative Techniques > Technology, Pharmaceutical > Dosage Forms > Drug Carriers > Virosomes

... > Technology > Technology, Pharmaceutical > Dosage Forms > Drug Carriers > Virosomes

Technology, Industry, and Agriculture > Manufactured Materials > Biomedical and Dental Materials > Membranes, Artificial > Virosomes

Chemical Actions and Uses > Specialty Uses of Chemicals > Biomedical and Dental Materials > Membranes, Artificial > Virosomes

Technology, Industry, and Agriculture > Manufactured Materials > Biomimetic Materials > Membranes, Artificial > Virosomes

Virosomes

Notice: Undefined index: in /var/www/html/model/Concept.php on line 545

Semi-synthetic complex derived from nucleic-acid free viral particles. They are essentially reconstituted viral coats, where the infectious nucleocapsid is replaced by a compound of choice. Virosomes retain their fusogenic activity and thus deliver the incorporated compound (antigens, drugs, genes) inside the target cell. They can be used for vaccines (VACCINES, VIROSOME), drug delivery, or gene transfer.

http://data.loterre.fr/ark:/67375/JVR-VNRL51HM-H

RDF/XML TURTLE JSON-LD Creado 22/6/00, última modificación 5/7/06

Loterre